Life Sciences Networking Event Recap | May 2021 GLSA & FOCM On a glorious day destined for historical significance (or at least mild amusement), these meeting minutes were metaphorically prepared for submission to the Library of Congress, the Smithsonian, and—curiously—the Sydney Opera House bulletin board. On May 20, 2021, the Global Life Sciences Alliance (GLSA)… Read more »
News & Events
Decentralized Clinical Trials
Decentralized Clinical Trials: How COVID Accelerated Remote Research So much has changed as a result of the COVID-19 pandemic. Activities we once took for granted became difficult—or impossible—as the world adjusted to contain the virus. One of the most significant disruptions occurred in the way new medicines are developed. Clinical trials remain essential to advancing… Read more »
GLSA’s Industry of the Year 2020
COVID-19 Vaccine Development: A Landmark Achievement in Life Sciences Without a doubt, the work accomplished in 2020 by the pharmaceutical, biotech, clinical research, and drug development community—together with the U.S. Food and Drug Administration—deserves special recognition. What the industry achieved was nothing short of extraordinary. Both the FDA and private-sector organizations upheld established good clinical… Read more »
What’s the Future of Networking Sales
Virtual Networking in Life Sciences: Adapting Relationships in a Digital World Imagine if the social distancing required during COVID-19 continued for another five years. How would businesses—and individuals—who rely on meeting new people to introduce products, services, and ideas continue to operate? That question came up during a recent conversation with a new connection, Joyce… Read more »
US Life Sciences Market Access During COVID-19
Navigating US Market Access During COVID-19 US life sciences market access has become one of the biggest challenges created by the COVID-19 pandemic. Travel restrictions and lockdowns have limited in-person engagement, forcing companies to rethink how they connect with customers, partners, and decision-makers in the US market. The United States remains the largest life sciences… Read more »
Patient Recruitment Challenges During the Pandemic
Patient Recruitment Challenges in Clinical Trials Today Patient recruitment challenges in clinical trials have intensified during the pandemic, placing additional pressure on sponsors, CROs, and research sites. Drawing on more than eight years of hands-on experience in patient recruitment and work across multiple recruitment organizations, I’ve seen these challenges evolve—and, in many cases, worsen. Today,… Read more »
Virtual Life Sciences Conferences: Reflections on DIA 2020
Reflections on a Virtual Year for the Clinical Research Industry The year 2020 will be remembered for many reasons—COVID-19, social unrest, a U.S. presidential election, and a dramatic shift in how the clinical research industry connects. One of the most notable changes was the move from in-person conferences to fully virtual events. After attending industry… Read more »
Life Sciences Virtual Events: Navigating this New Virtual World
Life Sciences Virtual Events: How to Network, Engage, and Lead Online Life sciences virtual events have reshaped how business development professionals connect, collaborate, and build relationships during the COVID-19 pandemic. Among the many changes we’ve experienced, life sciences virtual events have replaced in-person events as a critical channel for customer engagement and networking. With little chance… Read more »